Neuroplast
Vacis
EnzyTag
Hy2Care
Vertoro
Year of investment: 2018
Vertoro is developing a technology to enable the production of high-value applications such as Crude Lignin Oil (CLO) and char, from lignin, a waste bi-product of biofuel and paper production, thereby improving the economics of biofuels and reducing dependence on fossils.
Corporis Medical
Year of investment: 2017
Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocar closure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation.
TripleMed
Year of investment: 2017
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.
For more information on the company and product(s), please refer to the following video:
Kriya Materials
Year of investment: 2017
Kriya Materials is an innovative coatings company that focuses on high value coating formulations. It develops and manufactures its own tailor-made nanoparticles which form the basis for a wide range of coatings with unique, high-end properties.
Applications include displays, solar panels, window films and glasses.
Matisse Pharmaceuticals
Year of investment: 2016